Telerehabilitation program for COVID-19 survivors (TERECO) - Randomized controlled trial
收藏DataONE2021-07-11 更新2025-05-31 收录
下载链接：
https://search.dataone.org/view/sha256:359220638c69e55f22edf307915ece5b48469f7029080f6a09d7a3c93bf76309
下载链接
链接失效反馈官方服务：
资源简介：
Objectives
To investigate superiority of a telerehabilitation program for Covid-19 (TERECO) over no rehabilitation with regard to exercise capacity, lower-limb muscle strength (LMS), pulmonary function, health-related quality of life (HRQOL), and dyspnoea.
Design
Parallel-group randomised controlled-trial with 1:1 block-randomisation.
Setting
Three major hospitals from Jiangsu and Hubei provinces, China.
Participants
120 formerly hospitalised Covid-19 survivors with remaining dyspnoea complaints were randomised with 61 allocated to control and 59 to TERECO.
Intervention
Unsupervised home-based 6-week exercise program comprising breathing control and thoracic expansion, aerobic exercise, and LMS exercise, delivered via smartphone, and remotely monitored with heart rate telemetry.
Outcomes
Primary outcome was 6-minute walking distance (6MWD) in metres. Secondary outcomes were squat time in seconds; pulmonary function assessed by spirometry; HRQOL measured ...
创建时间：
2025-05-08
